News & Publications

Headlines in Reproductive Medicine

The following links have been gleaned from current news to help keep you informed on reproductive medicine's impact on our world. Note:  Some newspapers and periodicals require free registration to access their online articles. The links on this page may expire within a week of posting; however, most news web sites keep online archives with articles offered either free or available for purchase. WARNING! THE ASRM HAS NOT REVIEWED THE CONTENTS OF THE EXTERNAL WEB SITES LISTED ON THIS PAGE, NOR CAN WE ENDORSE THEM OR THE VIEWS EXPRESSED WITHIN.  

'Can't Get Enough of You Baby': IVF Clinic Says Vibrations from Barry White's Deep Soul Tracks 'Help Embryos to Develop'

Headlines in Reproductive Medicine July 12, 2016

A renowned fertility clinic has carried out a scientific study which claims musical vibrations increase the success of IVF. Songs from the late soul legend such as 'Can't get enough of you baby' have become the most streamed music through the iPods fitted in the incubators where embryos are developing.

First He Pioneered a New Way of Making Life. Now He Wants to Try it in People

Headlines in Reproductive Medicine July 12, 2016

The next great advance in fertility treatments may rest with five young monkeys in a lab outside of town. Each of the five carries genes from three parents instead of two, because they were conceived using a novel — and controversial — gene therapy. They seem to be completely ordinary. But researchers are watching them closely to make sure they age normally, can reproduce, and have healthy children.

1 in 8 Women Experience Infertility in The UK

Headlines in Reproductive Medicine July 12, 2016

One in eight women and one in 10 men in the U.K. have experienced infertility, struggling to get pregnant for at least a year, and almost half do not seek help for the problem, according to a new study.

Long Acting Reversible Contraception

Headlines in Reproductive Medicine July 12, 2016

The most commonly used contraceptives among adolescents are condoms, withdrawal and oral contraceptive pills. These methods are commonly chosen due to their accessibility, yet are inconsistently or incorrectly used, leading to high failure rates. Forty-three percent of unintended pregnancies are a result of inconsistent or incorrect use of contraceptives. A solution to this problem is long acting reversible contraception (LARC). LARC includes intrauterine devices (IUDs) and etonogestrel implants. LARC has been shown to be acceptable to teens and young women with higher continuation rates than short-acting methods.

Eggs Unlimited

Headlines in Reproductive Medicine November 06, 2015

OvaScience is preoccupied by an enduring mystery in human biology—why eggs fail—and the palpable hope that we can do something about it. On the company's homepage, a beautiful, smiling woman with red hair tumbling down her shoulders gazes at something off-screen. “A woman's biology is extraordinary,” the tagline reads. Venture capitalists fueled OvaScience with $40 million soon after it launched in 2011, and it raised more than $200 million after going public a year later.

Scientists Could One Day Create Genetically Modified ‘Designer Babies’ — But Should They?

Headlines in Reproductive Medicine June 18, 2015

This week, the Congressional Research and Technology Subcommittee held its first hearing on the science and ethics of genetically modifying human DNA. The main topic up for discussion was CRISPR, the world’s most promising and widely applicable gene-editing technique. So far, CRISPR (pronounced crisper) has been used by multiple labs around the world to modify the genes of organisms as varied as bacteria, plants, mice and some primates. But what lawmakers wanted to talk about with scientists this week is what it will mean when we start making genetic improvements to human beings.

FDA to Again Consider Drug Aimed at Women’s Sexual Dysfunction

Headlines in Reproductive Medicine June 04, 2015

The Food and Drug Administration said that safety concerns outweighed any benefits, and, in 2013, again rejected the drug for approval.The manufacturer, Sprout Pharmaceuticals resubmitted an application for approval in February with additional safety studies.And on Thursday, an advisory committee of the FDA will again examine the risks and rewards of the drug. Their vote could influence the final FDA decision, due in August.  


View Details
Learn More | Join | Renew
Back to Top